it is known to play a vital role in cell to cell recognition processes it is also a tumor marker used primarily in the management of pancreatic cancer ca19 9 is the sialylated form of lewis antigen it is a tetrasaccharide with the sequence neu5ac 2 3gal 1 3 fuc 1 4 glcnac guidelines from the american society of clinical oncology discourage the use of ca19 9 as a screening test for cancer particularly pancreatic cancer the reason is that the test may be falsely normal false negative in many cases or abnormally elevated in people who have no cancer at all false positive the main use of ca19 9 is therefore to see whether a pancreatic tumor is secreting it if that is the case then the levels should fall when the tumor is treated and they may rise again if the disease recurs therefore it is useful as a surrogate marker for relapse in people with pancreatic masses ca19 9 can be useful in distinguishing between cancer and other diseases of the gland ca19 9 can be elevated in many types of gastrointestinal cancer such as colorectal cancer esophageal cancer and hepatocellular carcinoma apart from cancer elevated levels